11h agoEric Topol says combining a personalized mRNA vaccine with pembrolizumab cuts melanoma recurrence or death by 49%The combination therapy also reduced distant metastasis by 59%SentimentSentimentPos50%Neg50%Positive users highlight mRNA technology advancing to real use cases in melanoma treatment trials, while negative users express pessimism that cancer will ultimately prevail.2 comments with sentiment. View comments.